Antimicrobial resistance
is a serious threat to human health worldwide,
prompting research efforts on a massive scale in search of novel antibiotics
to fill an urgent need for a remedy. Teixobactin, a macrocyclic depsipeptide
natural product, isolated from uncultured bacteria (Eleftheria
terrae), displayed potent activity against several Gram-positive
pathogenic bacteria. The distinct pharmacological profile and interesting
structural features of teixobactin with nonstandard amino acid (three d-amino acids and l-allo-enduracididine)
residues attracted several research groups to work on this target
molecule in search of novel antibiotics with new mechanism. Herein,
we present a comprehensive and critical perspective on immense possibilities
offered by teixobactin in the domain of drug discovery. Efforts made
by various research groups since its isolation are discussed, highlighting
the molecule’s considerable potential with special emphasis
on replacement of amino acids. Critical analysis of synthetic efforts,
SAR studies, and the way forward are provided hereunder.
Towards the total chemical synthesis of the exceptionally potent antibiotic teixobactin, we synthesized the macrocyclic core of a natural product by using a solution‐phase approach. The gramscale synthesis of l‐allo‐enduracididine and Shiina macrolactonization are highlights of the present disclosure.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.